1. Home
  2. ONCY vs NTIC Comparison

ONCY vs NTIC Comparison

Compare ONCY & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.94

Market Cap

98.7M

Sector

Health Care

ML Signal

HOLD

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

HOLD

Current Price

$8.85

Market Cap

83.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONCY
NTIC
Founded
1998
1970
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
98.7M
83.1M
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
ONCY
NTIC
Price
$0.94
$8.85
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.33
N/A
AVG Volume (30 Days)
1.6M
10.8K
Earning Date
05-08-2026
04-09-2026
Dividend Yield
N/A
0.49%
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
N/A
$84,234,474.00
Revenue This Year
N/A
$12.49
Revenue Next Year
$2,505.00
$7.64
P/E Ratio
N/A
$441.50
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$7.14
52 Week High
$1.51
$10.03

Technical Indicators

Market Signals
Indicator
ONCY
NTIC
Relative Strength Index (RSI) 52.82 82.04
Support Level $0.90 $8.55
Resistance Level $1.06 $9.00
Average True Range (ATR) 0.06 0.17
MACD 0.01 0.09
Stochastic Oscillator 62.80 100.00

Price Performance

Historical Comparison
ONCY
NTIC

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

Share on Social Networks: